Want to see ADRNY full AI Analyst Report?
Koninklijke Ahold Delhaize (ADRNY) AI Stock Analysis
Top Page
Koninklijke Ahold Delhaize
(Other OTC:ADRNY)
ADRNY scores well on financial quality and shareholder-return support (strong free cash flow generation, steady growth, and an attractive P/E with a ~3.75% dividend yield). The score is held back by weak technicals (below key moving averages with negative MACD) and ongoing operating headwinds highlighted on the call (U.S. margin pressure and macro/program impacts), despite reiterated full-year guidance.
Koninklijke Ahold Delhaize (ADRNY) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- $31.90B
- Dividend Yield
- 4.00%
- Average Volume (3M)
- 144.09K
- Price to Earnings (P/E)
- 13.0
- Beta (1Y)
- 0.04
- Revenue Growth
- 6.97%
- EPS Growth
- 33.25%
- Country
- US
- Employees
- 390,000
- Sector
- Consumer Defensive
- Sector Strength
- 62
- Industry
- Grocery Stores
Koninklijke Ahold Delhaize Business Overview & Revenue Model
Company Description
Koninklijke Ahold Delhaize N.V. is a prominent retail and e-commerce enterprise, primarily conducting its operations across the United States and Europe. The company's diverse physical footprint encompasses various retail formats, such as supermarket...
How the Company Makes Money
Ahold Delhaize primarily makes money by selling food and everyday consumer products through its grocery retail networks in the United States and Europe. The core revenue stream is retail sales generated in physical stores and through online grocery c...
Koninklijke Ahold Delhaize Earnings Call Summary
The call presents a generally positive operational and strategic picture: the company delivered modest top-line growth (net sales +1.9%), advanced own-brand penetration above 40%, achieved double-digit online growth and reported online profitability while gaining market share and reiterating full-year guidance. Offsetting these positives are margin compression in the U.S., one-off IFRS charges, a year-to-date free cash flow shortfall due to timing effects, and macro pressures (energy, SNAP/pharmacy impacts, competitive pricing and local pricing decrees). On balance the highlights (market share gains, online growth and strategic progress on own brands, AI and disciplined capital allocation) outweigh the lowlights, but management remains watchful about cost and macro dynamics.
Q2-2026 Updates
Positive Updates
Negative Updates
Company Guidance
Management reiterated full‑year 2026 guidance (on a 53‑week basis): underlying operating margin of around 4%, free cash flow of at least EUR 2.3 billion, gross capital expenditures of about EUR 2.7 billion, and diluted underlying EPS growth at mid‑ to high‑single‑digit rates on a constant currency basis. They confirmed execution of strategic actions including a EUR 1 billion price/own‑brand investment program (≈EUR 250m p.a. as part of a four‑year plan) and a trajectory to deliver roughly EUR 1.25 billion of cost savings this year, with flexibility to deepen price investments if needed. Management also guided that pharmacy headwinds in H2 should be similar to Q2, ag‑price deflational impact should be lower as they cycle last year, and the SNAP eligibility changes are expected to be a ~60–80 basis‑point headwind for the full year; for context Q2 reported net sales were EUR 23.2 billion, Q2 free cash flow EUR 632 million (YTD free cash flow EUR 302 million) and Q2 underlying operating margin was 3.9%.
Koninklijke Ahold Delhaize Financial Statement Overview
Summary
Solid fundamentals for a grocery retailer: TTM revenue grew ~8% and EBIT margin improved versus 2024–2025, while free cash flow generation is strong (TTM FCF ~5.6B). The main constraint is structurally thin profitability (TTM net margin ~2.4%) and still-meaningful leverage (debt-to-equity ~1.08x), which reduces cushion if costs or pricing pressures intensify.
Income Statement
74PositiveBalance Sheet
64PositiveCash Flow
78Positive| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 91.42B | 92.35B | 89.36B | 88.73B | 86.98B | 75.60B |
| Gross Profit | 24.32B | 24.51B | 23.80B | 23.85B | 23.30B | 20.68B |
| EBITDA | 7.39B | 6.73B | 6.48B | 6.50B | 7.27B | 6.34B |
| Net Income | 2.34B | 2.26B | 1.76B | 1.87B | 2.55B | 2.25B |
Balance Sheet | ||||||
| Total Assets | 49.66B | 49.09B | 51.84B | 47.82B | 48.55B | 45.71B |
| Cash, Cash Equivalents and Short-Term Investments | 3.55B | 3.93B | 6.17B | 3.48B | 3.21B | 3.13B |
| Total Debt | 15.63B | 18.40B | 20.34B | 17.79B | 17.67B | 17.09B |
| Total Liabilities | 35.21B | 34.89B | 36.39B | 33.07B | 33.15B | 31.99B |
| Stockholders Equity | 14.45B | 14.20B | 15.45B | 14.76B | 15.40B | 13.72B |
Cash Flow | ||||||
| Free Cash Flow | 5.58B | 4.15B | 3.92B | 3.99B | 3.62B | 3.10B |
| Operating Cash Flow | 6.88B | 6.99B | 6.22B | 6.47B | 6.11B | 5.47B |
| Investing Cash Flow | -2.43B | -3.58B | -1.73B | -2.21B | -2.01B | -2.63B |
| Financing Cash Flow | -5.39B | -5.68B | -1.98B | -3.78B | -4.19B | -3.05B |
Koninklijke Ahold Delhaize Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For ADRNY, the sentiment is Neutral. The current price of 36.56 is above the 20-day moving average (MA) of 36.22, above the 50-day MA of 36.20, and below the 200-day MA of 40.92, indicating a neutral trend. The MACD of 0.11 indicates Negative momentum. The RSI at 52.04 is Neutral, neither overbought nor oversold. The STOCH value of 13.80 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for ADRNY.
Koninklijke Ahold Delhaize Risk Analysis
Koninklijke Ahold Delhaize disclosed 49 risk factors in its most recent earnings report. Koninklijke Ahold Delhaize reported the most risks in the "Finance & Corporate" category.
Latest Risks Added
0 New RisksKoninklijke Ahold Delhaize Peers Comparison
Overall Rating
ADRNY70Outperform
IMKTA62Neutral
KR61Neutral
WMK61Neutral
SFM55Neutral
ACI54Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 70Outperform | $31.81B | 13.00 | 15.64% | 4.00% | 6.97% | 33.25% | |
| Sector * | 62Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% |
| 62Neutral | $1.56B | 15.05 | 6.30% | 0.78% | 1.02% | 84.32% | |
| 61Neutral | $39.43B | 36.09 | 17.17% | 2.16% | 1.58% | -53.21% | |
| 61Neutral | $1.84B | 18.93 | 7.15% | 1.83% | 4.50% | -3.08% | |
| 55Neutral | $4.58B | 9.47 | 33.82% | ― | 5.25% | 0.53% | |
| 54Neutral | $6.15B | -436.00 | -2.78% | 5.05% | 2.26% | -106.73% |
* Consumer Defensive Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| ADRNY | Koninklijke Ahold Delhaize N.V. | 36.56 | -3.09 | -7.79% | |
| IMKTA | Ingles Markets Inc | 84.11 | 13.09 | 18.44% | |
| KR | Kroger Company | 66.76 | 4.73 | 7.62% | |
| WMK | Weis Markets | 74.41 | 11.87 | 18.98% | |
| SFM | Sprouts Farmers Market | 49.70 | -34.12 | -40.71% | |
| ACI | Albertsons Companies, Inc. | 13.08 | -3.72 | -22.12% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Aug 10, 2026